Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,268,585,398
-
Total 13F shares
-
1,014,230,760
-
Share change
-
-11,500,362
-
Total reported value
-
$63,831,005,436
-
Put/Call ratio
-
81%
-
Price per share
-
$62.88
-
Number of holders
-
1,823
-
Value change
-
-$677,262,119
-
Number of buys
-
613
-
Number of sells
-
1,196
Institutional Holders of CVS HEALTH Corp - Common Stock (CVS) as of Q3 2024
As of 30 Sep 2024,
CVS HEALTH Corp - Common Stock (CVS) was held by
1,823 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,014,230,760 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., Dodge & Cox, STATE STREET CORP, Capital World Investors, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, Capital International Investors, MORGAN STANLEY, and NORGES BANK.
This page lists
1,826
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.